ShangBay Capital LLC — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Petal Surgicalpetal.healthAug 2025✓ verified
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prashant Chopra(Executive Officer, Director, Promoter)Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Rony Abovitz(Co-founding Advisor)
BoardFrederic Moll(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.